Novel peptides and methods for their preparation and use

Details for Australian Patent Application No. 2011232597 (hide)

Owner Eli Lilly and Company

Inventors Alsina-Fernandez, Jorge; Bokvist, Krister Bengt; Guo, Lili; Mayer, John Philip

Agent Wrays

Pub. Number AU-A-2011232597

PCT Pub. Number WO2011/119657

Priority 61/317,850 26.03.10 US

Filing date 23 March 2011

Wipo publication date 29 September 2011

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/26 Medicinal preparations containing peptides - Glucagons

A61K 38/30 Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

C07K 14/605 Peptides having more than 20 amino acids

C07K 14/62 Peptides having more than 20 amino acids

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/119657 Priority application(s): WO2011/119657

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232607-Adjusting drug loading in polymeric materials

2011232577-Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics